Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts


  Free Subscription


1 Am J Cardiol
1 Am J Med
1 Ann Intern Med
1 Atherosclerosis
1 Circ Cardiovasc Interv
3 N Engl J Med
1 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Am J Cardiol

  1. GAUDET D, Watts GF, Robinson JG, Minini P, et al
    Effect of Alirocumab on Lipoprotein(a) Over >/=1.5 Years (from the Phase 3 ODYSSEY Program).
    Am J Cardiol. 2017;119:40-46.
    PubMed     Text format     Abstract available

    Am J Med

  2. NOEL ZR, Beavers CJ
    Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: A Brief Overview.
    Am J Med. 2017;130:229.
    PubMed     Text format     Abstract available

    Ann Intern Med

  3. LAUFFENBURGER JC, Shrank WH, Bitton A, Franklin JM, et al
    Association Between Patient-Centered Medical Homes and Adherence to Chronic Disease Medications: A Cohort Study.
    Ann Intern Med. 2017;166:81-88.
    PubMed     Text format     Abstract available


  4. BOURBON M, Alves AC, Alonso R, Mata N, et al
    Mutational analysis and genotype-phenotype relation in familial hypercholesterolemia: The SAFEHEART registry.
    Atherosclerosis. 2017;262:8-13.
    PubMed     Text format     Abstract available

    Circ Cardiovasc Interv

  5. GASIOR P, Cheng Y, Valencia AF, McGregor J, et al
    Impact of Fluoropolymer-Based Paclitaxel Delivery on Neointimal Proliferation and Vascular Healing: A Comparative Peripheral Drug-Eluting Stent Study in the Familial Hypercholesterolemic Swine Model of Femoral Restenosis.
    Circ Cardiovasc Interv. 2017;10.
    PubMed     Text format     Abstract available

    N Engl J Med

  6. RIDKER PM, Revkin J, Amarenco P, Brunell R, et al
    Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients.
    N Engl J Med. 2017 Mar 17. doi: 10.1056/NEJMoa1701488.
    PubMed     Text format     Abstract available

  7. RIDKER PM, Tardif JC, Amarenco P, Duggan W, et al
    Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab.
    N Engl J Med. 2017;376:1517-1526.
    PubMed     Text format     Abstract available

  8. SABATINE MS, Giugliano RP, Keech AC, Honarpour N, et al
    Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.
    N Engl J Med. 2017 Mar 17. doi: 10.1056/NEJMoa1615664.
    PubMed     Text format     Abstract available

    PLoS One

  9. FUSCO FB, Gomes DJ, Bispo KCS, Toledo VP, et al
    Low-sodium diet induces atherogenesis regardless of lowering blood pressure in hypertensive hyperlipidemic mice.
    PLoS One. 2017;12:e0177086.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Hyperlipoproteinemias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.